Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

“ImmunogenX” (a subsidiary of Immunogenics LLC) is a clinical-stage company founded in 2013 and supported by a team of world renowned scientists and collaborators. ImmunogenX was formed to address critical needs for individuals with suspected or diagnosed celiac disease. Our research efforts are focused on therapy, disease management, and food safety. The only current recourse for an individual with celiac disease is a ...
“ImmunogenX” (a subsidiary of Immunogenics LLC) is a clinical-stage company founded in 2013 and supported by a team of world renowned scientists and collaborators. ImmunogenX was formed to address critical needs for individuals with suspected or diagnosed celiac disease. Our research efforts are focused on therapy, disease management, and food safety. The only current recourse for an individual with celiac disease is a lifelong adherence to a gluten-free diet (GFD). A first area of development is a therapy for the treatment of patients exercising a diligent GFD.

List your booth number for exhibitions, ask us